Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice (2004)

  • Authors:
  • USP affiliated authors: SILVA, CELIO LOPES - FMRP ; FACCIOLI, LUCIA HELENA - FCFRP
  • USP Schools: FMRP; FCFRP
  • DOI: 10.1038/sj.gt.3302418
  • Subjects: TUBERCULOSE; VACINAS; IMUNOGENÉTICA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1038/sj.gt.3302418 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Gene Therapy

    ISSN: 0969-7128

    Citescore - 2017: 2.91

    SJR - 2017: 1.277

    SNIP - 2017: 0.716


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FCFRP10600012901-Spcd 1417367
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SILVA, Célio Lopes; BONATO, Vânia Luiza Deperon; COELHO-CASTELO, Arlete Aparecida Martins; et al. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice. Gene Therapy, London, 2004. DOI: 10.1038/sj.gt.3302418.
    • APA

      Silva, C. L., Bonato, V. L. D., Coelho-Castelo, A. A. M., Souza, A. O. de, Santos, S. A., Lima, K. M., et al. (2004). Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice. Gene Therapy. doi:10.1038/sj.gt.3302418
    • NLM

      Silva CL, Bonato VLD, Coelho-Castelo AAM, Souza AO de, Santos SA, Lima KM, Faccioli LH, Rodrigues JM. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice. Gene Therapy. 2004 ;
    • Vancouver

      Silva CL, Bonato VLD, Coelho-Castelo AAM, Souza AO de, Santos SA, Lima KM, Faccioli LH, Rodrigues JM. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice. Gene Therapy. 2004 ;

    Referências citadas na obra
    Kochi A . Global challenge of tuberculosis. Lancet 1994; 44: 608–609.
    Young DB, Duncan K . Prospects for new interventions in the treatment and prevention of mycobacterial disease. Annu Rev Microbiol 1995; 49: 641–673.
    Bass Jr JB et al. Treatment of tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149: 1359–1374.
    Mitchison DA . The action of antituberculosis drugs in short-course chemotherapy of M. tuberculosis. Tubercle 1985; 66: 219.
    Manabe YC, Bishai WR . Latent Mycobacterium tuberculosis – persistence, patience, and winning by waiting. Nat Med 2000; 6: 1327–1329.
    Kaufmann SHE . Is the development of a new tuberculosis vaccine possible? Nat Med 2000; 6: 955–960.
    Lowrie DB, Tascon RE, Colston MJ, Silva CL . Towards a DNA vaccine against tuberculosis. Vaccine 1994; 12: 1537–1540.
    Tascon RE et al. Vaccination against tuberculosis by DNA injection. Nat Med 1996; 2: 888–892.
    Bonato VLD et al. Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice. Infect Immun 1998; 66: 169–175.
    Silva CL, Lowrie DB . Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis. Infec Immun 2000; 68: 3269–3274.
    Lowrie DB et al. Therapy of tuberculosis in mice by DNA vaccination. Nature 1999; 400: 269–271.
    Lowrie DB, Silva CL . Enhancement of immunocompetence in tuberculosis by DNA vaccination. Vaccine 2000; 18: 1712–1716.
    Ha SJ et al. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis. Gene Therapy 2003; 10: 1592–1599.
    Lai WC et al. Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis. J Immunol 1997; 158: 2513–2516.
    Collins HL, Kaufmann SHE . The many faces of host responses to tuberculosis. Immunology 2001; 103: 1–9.
    Flynn JL, Ernst JD . Immune responses in tuberculosis. Curr Opin Immunol 2000; 12: 432–438.
    Silva CL et al. Characterization of the memory/activated T cells that mediate the long-lived host response against tuberculosis after bacillus Calmette–Guérin or DNA vaccination. Immunology 1999; 97: 573–581.
    Yang ZY et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 2004; 428: 861–864.
    Lima KM et al. Comparison of different delivery systems of vaccinations for the induction of protection against tuberculosis in mice. Vaccine 2001; 19: 3518–3525.
    Lima KM et al. Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo. Vaccine 2003; 22: 49–56.
    De Wit D, Wootton M, Dhillon J, Mitchison DA . The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis. Tubercle Lung Dis 1995; 76: 555–562.
    Flynn JL et al. An essential role for interferon γ in resistance to Mycobacterium tuberculosis. J Exp Med 1993; 178: 2249–2254.
    Orme IM, Cooper AM . Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today 1999; 20: 307–312.
    Butcher EC, Picker LJ . Lymphocyte homing and homeostasis. Science 1996; 272: 60–66.
    Mackay CR . Homing of naive, memory and effector lymphocytes. Curr Opin Immunol 1993; 5: 423–427.
    Trinchieri G . Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13: 251–276.
    Sallusto F et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708–712.
    Abbas AK, Murphy KM, Sher A . Functional diversity of helper T lymphocytes. Nature 1996; 383: 787–793.
    Lazanvecchia A . Identifying strategies for immune intervention. Science 1993; 260: 937–944.
    Thomson J . New TB vaccines to be tested. Nat Med 2001; 7: 1263.
    Enserink M . Driving a stake into resurgent TB. Science 2001; 293: 234–235.